Sign up for the QMED & MD+DI Daily newsletter.
5 Wow-Worthy Global Medtech Startups (Japan)
July 3, 2014
1 Min Read
This Japanese upstart company may be a game-changer in genome sequencing. The Osaka company is developing single-molecule electrical sequencing of DNA and applies quantum mechanics to the field of genome sequencing.
Quantum Biosystem's methodology does not use reagents, proteins and other materials that make genome sequencing an expensive affair. Companies like Illumina have turned heads by achieving the $1,000 genome, but it appears that Quantum seeks to reduce it even further, while making the sequencing more accurate. Its sequencers are nano chips that are essentially silicon semiconductor chips in that they can be mass produced.
As such, if successful Quantum can make gene sequencing dramatically cheaper and accessible by the average person. Here are a few screenshots from the company's website that explains the promise of its technology:
[Flag Image Credit: iStockphoto.com user pop_jop]
You May Also Like
Pedersen's POV graphic featuring the headshot of MD+DI Senior Editor Amanda Pedersen and a pull quote from the latest edition of her opinion column.
BioSig's Ridiculously Sparse Layoff Announcement Reeks of CallousnessFeb 26, 2024|3 Min Read
Sourcing Electrical Components: Are We Back to Normal?Feb 26, 2024|6 Min Read
Your Smartwatch Can’t Measure Blood Glucose Levels… YetFeb 26, 2024|3 Min Read
Medtech in a Minute: Medtronic Pulls the Plug on Ventilators and MoreFeb 26, 2024|1 Min Read